Literature DB >> 20035511

Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.

Andrew P D Henderson1, Michael H Barnett, John D E Parratt, John W Prineas.   

Abstract

OBJECTIVE: CD4 T-cell-dependent macrophage activation directed against a myelin or oligodendrocyte antigen is generally thought to be the mechanism causing myelin destruction in multiple sclerosis (MS). However, areas within expanding MS lesions may exhibit prominent oligodendrocyte loss and apoptosis in the absence of infiltrating lymphocytes. The present study was designed to further investigate the inflammatory profile of different regions within rapidly expanding MS lesions.
METHODS: Twenty-six active lesions from 11 patients with early MS were serially sectioned and immunostained for T and B cells, plasma cells, ramified microglia, macrophages, monocytes, and CD209-positive dendritic cells. Cell counts were compared in prephagocytic, phagocytic, and immediately postphagocytic areas.
RESULTS: Parenchymal T and B cells were largely absent in areas of initial oligodendrocyte loss and in areas of degenerate and dead myelin infiltrated by myelin phagocytes. In contrast, trailing areas of complete demyelination packed with lipid macrophages, and, in some lesions, regenerating oligodendrocytes, showed large numbers of T cells, B cells, and immunoglobulin G (IgG)-positive plasma cells. Lesions in 2 exceptionally early cases contained relatively few T and B cells, and no IgG-positive plasma cells.
INTERPRETATION: Early loss of oligodendrocytes is a prominent feature in tissue bordering rapidly expanding MS lesions. Macrophage activity is largely an innate scavenging response to the presence of degenerate and dead myelin. Adaptive immune activity involving T and B cells is conspicuous chiefly in recently demyelinated tissue, which may show signs of oligodendrocyte regeneration. The findings suggest that plaque formation has some basis other than destructive cell-mediated immunity directed against a myelin or oligodendrocyte antigen.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20035511     DOI: 10.1002/ana.21800

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  120 in total

1.  Chronic cerebrospinal venous insufficiency in multiple sclerosis: a historical perspective.

Authors:  Michael D Dake; Robert Zivadinov; E Mark Haacke
Journal:  Funct Neurol       Date:  2011 Oct-Dec

Review 2.  Multiple sclerosis genetics--is the glass half full, or half empty?

Authors:  Jorge R Oksenberg; Sergio E Baranzini
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

3.  High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity.

Authors:  Hisham Qosa; Loqman A Mohamed; Sweilem B Al Rihani; Yazan S Batarseh; Quoc-Viet Duong; Jeffrey N Keller; Amal Kaddoumi
Journal:  J Alzheimers Dis       Date:  2016-07-06       Impact factor: 4.472

Review 4.  Myeloid Cells in the Central Nervous System.

Authors:  Jasmin Herz; Anthony J Filiano; Ashtyn Smith; Nir Yogev; Jonathan Kipnis
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

5.  Sample-size calculations for short-term proof-of-concept studies of tissue protection and repair in multiple sclerosis lesions via conventional clinical imaging.

Authors:  Daniel S Reich; Richard White; Irene Cm Cortese; Luisa Vuolo; Colin D Shea; Tassie L Collins; John Petkau
Journal:  Mult Scler       Date:  2015-02-06       Impact factor: 6.312

6.  MiR-30a Positively Regulates the Inflammatory Response of Microglia in Experimental Autoimmune Encephalomyelitis.

Authors:  Xue Fang; Dingya Sun; Zhihong Wang; Zhongwang Yu; Weili Liu; Yingyan Pu; Dan Wang; Aijun Huang; Mingdong Liu; Zhenghua Xiang; Cheng He; Li Cao
Journal:  Neurosci Bull       Date:  2017-07-17       Impact factor: 5.203

7.  Translocator protein PET imaging for glial activation in multiple sclerosis.

Authors:  Unsong Oh; Masahiro Fujita; Vasiliki N Ikonomidou; Iordanis E Evangelou; Eiji Matsuura; Erin Harberts; Yota Fujimura; Nancy D Richert; Joan Ohayon; Victor W Pike; Yi Zhang; Sami S Zoghbi; Robert B Innis; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2010-09-25       Impact factor: 4.147

8.  The L-coding region of the DA strain of Theiler's murine encephalomyelitis virus causes dysfunction and death of myelin-synthesizing cells.

Authors:  G D Ghadge; R Wollmann; G Baida; M Traka; R P Roos
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

9.  Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination.

Authors:  Andrew V Caprariello; Saisho Mangla; Robert H Miller; Stephen M Selkirk
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

10.  Monocyte and Lymphocyte Activation and Regulation in Multiple Sclerosis Patients. Therapy Effects.

Authors:  M C González-Oria; M Márquez-Coello; J A Girón-Ortega; J Argente; M Moya; José-Antonio Girón-González
Journal:  J Neuroimmune Pharmacol       Date:  2019-01-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.